378 related articles for article (PubMed ID: 14671160)
1. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
[TBL] [Abstract][Full Text] [Related]
2. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
3. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
4. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
5. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.
Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT
J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850
[TBL] [Abstract][Full Text] [Related]
6. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
[TBL] [Abstract][Full Text] [Related]
8. Testolactone treatment of precocious puberty in McCune-Albright syndrome.
Foster CM; Pescovitz OH; Comite F; Feuillan P; Shawker T; Loriaux DL; Cutler GB
Acta Endocrinol (Copenh); 1985 Jun; 109(2):254-7. PubMed ID: 3925675
[TBL] [Abstract][Full Text] [Related]
9. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
[TBL] [Abstract][Full Text] [Related]
10. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
11. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
12. Ovarian function in girls with McCune-Albright syndrome.
Foster CM; Feuillan P; Padmanabhan V; Pescovitz OH; Beitins IZ; Comite F; Shawker TH; Loriaux DL; Cutler GB
Pediatr Res; 1986 Sep; 20(9):859-63. PubMed ID: 3092175
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
14. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
Foster CM; Ross JL; Shawker T; Pescovitz OH; Loriaux DL; Cutler GB; Comite F
J Clin Endocrinol Metab; 1984 Jun; 58(6):1161-5. PubMed ID: 6427261
[TBL] [Abstract][Full Text] [Related]
15. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue.
Schmidt H; Kiess W
J Pediatr Endocrinol Metab; 1998; 11(1):77-81. PubMed ID: 9642633
[TBL] [Abstract][Full Text] [Related]
16. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
[TBL] [Abstract][Full Text] [Related]
17. Use of aromatase inhibitors in precocious puberty.
Feuillan P; Merke D; Leschek EW; Cutler GB
Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123
[TBL] [Abstract][Full Text] [Related]
18. Comparison of triptorelin acetate vs triptorelin pamoate in the treatment of Central precocious puberty (CPP): a retrospective study.
Lasorella S; Porto R; Iezzi ML; Pistone C; Marseglia GL; Verrotti A; Brambilla I
Gynecol Endocrinol; 2020 Apr; 36(4):338-340. PubMed ID: 31441342
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
20. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
